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Stressful events during adulthood are potent adverse
environmental factors that can predispose individ-
uals to psychiatric disorders, including depression;
however, many individuals exposed to stressful
events can adapt and function normally. While stress
vulnerability may influence depression, the molec-
ular mechanisms underlying the susceptibility and
adaptation to chronic stress within the brain are
poorly understood. In this study, two genetically
distinct mouse strains that exhibit different behav-
ioral responses to chronic stress were used to
demonstrate how the differential epigenetic status
of the glial cell-derived neurotrophic factor (Gdnf)
gene in the ventral striatum modulates susceptibility
and adaptation to chronic stress. Our results suggest
that the histone modifications and DNA methylation
of theGdnf promoter have crucial roles in the control
of behavioral responses to chronic stress. Our data
provide insights into these mechanisms, suggesting
that epigenetic modifications of Gdnf, along with
genetic and environmental factors, contribute to
behavioral responses to stress.
INTRODUCTION
Major depressive disorder is one of the most common and
serious health problems in societies worldwide. While the
etiology of this disorder is multifactorial and poorly understood,
both genetic and environmental factors may be involved in the
precipitation of depression (Charney and Manji, 2004; Krishnan
andNestler, 2008; Feder et al., 2009). Chronic stressful life events
during adulthood are potent adverse environmental factors that
can activate or amplify the expression of depression symptoms
(Leonardo and Hen, 2008). Many individuals exposed to stress-
ful events do not show signs or symptoms of depression;
however, some individuals exposed to psychological stress are
predisposed to major depression (Charney, 2004). Thus far, themolecular mechanisms underlying the susceptibility and adapta-
tion to chronic stress within the brain are poorly understood.
Genetically distinct mouse strains that exhibit substantial
differences in anxiety and stress reactivity have been used as
animal models for investigating the influence of genetic and envi-
ronmental factors on brain functions and behaviors (Francis
et al., 2003; Hovatta et al., 2005; Mozhui et al., 2010). In partic-
ular, the inbred BALB/c (BALB) mouse strain demonstrates
unique responses to stress. Compared to the C57BL/6 (B6)
stress-resilient strain, BALB mice show maladaptive responses
to stressful stimuli (Francis et al., 2003; Hovatta et al., 2005;
Bhansali et al., 2007; Palumbo et al., 2009). Therefore, BALB
mice are considered a stress-vulnerable strain, and comparing
the stress responses of BALB and B6 mice may provide useful
information regarding the mechanisms of susceptibility and
adaptation to stressful stimuli in brain function and behavior,
such as those associated with depression.
Neuronal activity regulates a complex program of gene
expression that is involved in the structural and functional plas-
ticity of the brain (Flavell and Greenberg, 2008). There is also
increasing evidence indicating that aberrant transcription regula-
tion is one of the key components in the pathophysiology of
depression (Tsankova et al., 2007; Krishnan and Nestler, 2008;
Feder et al., 2009). Recent reports have suggested that the
epigenetic regulation of genes, such as DNA methylation and
histone modification, can trigger the development of stress
vulnerability and contribute to the behavioral responses to
chronic stress and antidepressants (Weaver et al., 2004;
Tsankova et al., 2006; Fyffe et al., 2008; Jakobsson et al.,
2008; LaPlant et al., 2010). However, the role of environmental
factors along with genetic factors in the epigenetic regulation
of the pathogenesis of depression is largely unknown.
The aim of the present study was to clarify the molecular
mechanisms underlying the susceptibility and adaptation to
chronic stress using stress-vulnerable BALB and stress-resilient
B6 mice strains. Our results show that the differential epigenetic
status of the glial cell-derived neurotrophic factor (Gdnf) gene in
the nucleus accumbens (NAc) influences differential behavioral
responses to stress. Therefore, we propose that epigenetic
regulation of Gdnf by environmental factors, along with genetic
factors, contributes to the level of susceptibility and adaptation
ability of individuals to chronic stressful life events.Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc. 359
Table 1. Summary of Behavioral Characterizations of B6 and BALB Mice Subjected to CUMS
Behavioral Assay Phenotype Tested





Versus Nonstressed B6 Versus Nonstressed BALB
Forced swim test Immobility time 4 [ 4 Y
Latency to immobility 4 Y 4 [
First immobility time 4 [ 4 4
Sucrose preference test Preference ratio 4 Y 4 4
Total (water + sucrose) intake 4 4 4 4
Social interaction test Interaction time [ Y 4 4
Total number of interactions 4 Y 4 4
Novelty-suppressed
feeding test
Latency to feed Y [ 4 Y
Food consumption 4 4 4 4
Body weight loss 4 4 4 4
This table shows the behavioral differences between B6 and BALB mice subjected to CUMS conditions for 6 weeks. Also shown are the effects of
3 weeks of antidepressant treatment in stressed and non-stressed BALB mice.4, no change; [, significantly greater changes; Y, significantly fewer
changes. IMI; imipramine.
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Complete statistical summaries of behavior, gene expression by
quantitative real-time PCR (Q-PCR) and Western blotting, and
chromatin immunoprecipitation (ChIP) data are provided in
Tables S1, S2, and S3 (available online), respectively.
Differential Behavioral Responses to Chronic
Stress in B6 and BALB Mice
We first investigated the behavioral consequences of 6 weeks of
chronic ultra-mild stress (CUMS) exposure, a procedure based
solely on environmental and social stressors that do not include
food or water deprivation (Lanfumey et al., 1999; Rangon et al.,
2007), in BALB and B6 mice. The experimental design is shown
in Figure S1A, and the results are summarized in Table 1. Anhe-
donia, diminished interest or pleasure, is one of the core
symptoms of major depression (Wong and Licinio, 2001). There-
fore, we examined whether this trait was present in stressed
BALB mice using a sucrose preference test (Figures S2A and
S2B). CUMS significantly decreased sucrose preference, and
this effect was reversed by continuous treatment (via drinking
water) with imipramine (IMI, 18 mg/kg/day), a tricyclic antide-
pressant (Figure S2A). Total fluid intake was not affected by
either treatment (Figure S2B). We then subjected BALB mice
to the acute forced swim test, which uses increased immobility
time as an index of behavioral despair (Porsolt et al., 1977).
CUMS significantly increased immobility times (Figure S2C)
and the duration of the first immobility episode (Figure S2D)
and reduced the latency to the first immobility episode (Fig-
ure S2E). These behavioral effects were reversed with contin-
uous IMI treatment (Figures S2C–S2E).
Anxiety is frequently comorbid in patients with major depres-
sion. To examine the effects of CUMS on anxiety behavior, we
performed the novelty-suppressed feeding test. The latency to
begin eating in a novel environment has been used as an index
of anxiety behavior (Richardson-Jones et al., 2010). Stressed
BALB mice showed significantly longer latency periods to360 Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc.feeding (Figure S2F), with no significant differences in weight
loss induced by food deprivation (Figure S2G) or feeding activi-
ties (Figure S2H). Furthermore, the increased latency to feed
induced by CUMS was reversed with continuous IMI treatment
(Figure S2F). Anxiety behavior was also examined using the
elevated zero maze test. The amount of time spent in the open
section and frequency of rearing were not affected by CUMS
(data not shown). Social interaction time also provides an index
of anxiety and depression-like behavior. More anxious and
depressed rodents spend less time in social interactions (File
and Seth, 2003; Berton et al., 2006). Stressed BALB mice spent
significantly less time engaged in social interactions and had
fewer interactions than the nonstressed controls. This effect
was also reversed with continuous IMI treatment (Figures S2I
and S2J). Taken together, these results indicate an increase
in depression- and anxiety-related behaviors in stressed BALB
mice.
In contrast with the BALB mice, B6 mice subjected to CUMS
did not show any behavioral changes in the sucrose preference
test (Figures S3A and S3B) or forced swim test (Figures S3C and
S3D), but they did demonstrate a reduced latency to feed in the
novelty-suppressed feeding test (Figure S3E) and increased
interaction times in the social interaction test (Figure S3G),
suggesting a decrease in anxiety-related behaviors in stressed
B6 mice. In addition to behavioral characterization, we also
examined the plasma corticosterone (CORT) levels of mice to
investigate how CUMS influences neuroendocrine function. We
found increased plasma CORT levels 60 min after the initiation
of a stressor in both BALB and B6 mice on day 3 of the CUMS
session (Figures S4A and S4B). In contrast, on day 38 of the
CUMS session, B6 mice showed a reduction in plasma CORT
levels 60 min after the initiation of the stressor (Figure S4B).
This effect was not observed in BALB mice (Figure S4A). Thus,
BALB mice responded to CUMS with an increase in depres-
sion-like phenotypes, whereas the B6 mice responded to the
same stress conditions with a decrease in anxiety-related
behaviors. These behavioral and neuroendocrine data indicate
Figure 1. Differential Regulation of Gdnf Expression in Stress-Susceptible and Stress-Adaptive Mice Strains
(A) mRNA expression ofGdnf in the dSTR and vSTR of BALBmice subjected to CUMS or nonstress (NS) conditions with or without continuous IMI (18mg/kg/day)
treatment (n = 6 per group; *p < 0.05 versus NS mice receiving vehicle (normal water) in corresponding brain regions).
(B) mRNA expression ofGdnf in the dSTR and vSTR of B6mice subjected to CUMS or NS conditions (n = 6 per group; *p < 0.05 versus NS in corresponding brain
regions).
(C) Levels of GDNF proteins in the dSTR and vSTR of BALB and B6mice subjected to CUMS or NS conditions with or without continuous IMI treatment (n = 8–12
per group; *p < 0.05 versus NS mice receiving water in corresponding brain regions).
(D–G) Correlation analyses of GDNF levels in the vSTR of nonstressed BALB (black line) and B6 (red line) mice and (D) the social interaction times (BALB; n = 21,
B6; n = 12), (E) the sucrose preferences (BALB; n = 28, B6; n = 16), (F) the immobility times in the forced swim test (BALB; n = 28, B6; n = 16), and (G) the latency to
feed in the novelty-suppressed feeding test (BALB; n = 28, B6; n = 16) (*p < 0.05).
(H and I) Successful transductions of EGFP (H) and GDNF (I) into the NAc using the PEI gene delivery system are shown.
(J and K) Effects of GDNF overexpression in the NAc of nonstressed B6 and stressed BALBmice (n = 14–19 per group) on social interaction times (J) and sucrose
preference (K) (*p < 0.05 versus PEI/Egfp in corresponding strains). Data are presented as mean ± SEM.
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responses to stress, suggesting that these strains of mice are
susceptible and adaptive strains to CUMS, respectively.
Expression Analyses of a Variety of Neurotrophic
Factors in a Mouse Model of Depression
Neurotrophic factors play important roles in the regulation of
synaptic and structural plasticity in the brain and may be
involved in depression (Nestler et al., 2002; Duman and Monteg-
gia, 2006). To investigate the contribution of neurotrophic factors
to the behavioral abnormalities of stressed BALB mice, the
mRNA levels of multiple neurotrophic factors were examined,
including Bdnf, Gdnf, Vegf, Nt-3, Nt-4/5, Cdnf, Ngf, Fgf2, and
Igf1, in regions of the brain associated with stress, such as the
hippocampus (HP), prefrontal cortex, amygdala, striatum
(STR), and hypothalamus, of BALB mice subjected to 6 weeks
of CUMS either with or without continuous IMI treatment.Q-PCR revealed that the expression levels of Bdnf, Vegf, and
Igf1 mRNA were significantly increased by continuous IMI
treatment, but were not affected by CUMS (Figures S5B, S5D,
and S5H). Interestingly, the mRNA levels of Gdnf and Nt-3 in
the STR and HP, respectively, were significantly decreased by
CUMS, and these effects were reversed by continuous IMI treat-
ment (Figures S5A and S5E). In addition, the mRNA expression
level of Gdnf in stressed BALB mice was significantly decreased
in both the dorsal STR (dSTR) and the ventral STR (vSTR)
(Figure 1A). On the contrary, the mRNA expression level of
Gdnf in stressed B6 mice was significantly increased in the
vSTR but not in the dSTR (Figure 1B). These changes in GDNF
expression were confirmed at the protein level using an ELISA
assay (Figure 1C). These results suggest that the transcriptional
regulation ofGdnf in the vSTR is differentially regulated in the two
mouse strains and may contribute to the observed behavioral
responses to CUMS.Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc. 361
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We next investigated whether a correlation exists between Gdnf
expression in the vSTR and behavioral performances in mice.
We found that GDNF protein levels in the vSTR of nonstressed
BALB and B6mice were significantly correlated with social inter-
action time (Figure 1D) and sucrose preferences (Figure 1E), but
not with immobility times in the forced swim test (Figure 1F) or
the latency to feed in the novelty-suppressed feeding test (Fig-
ure 1G). These data suggest an important role for GDNF in the
vSTR for determining certain types of depression-like behaviors.
To directly investigate the role of GDNF in depression-like
behaviors, GDNF was overexpressed in the NAc of mice using
the polyethylenimine (PEI) gene delivery system. The experi-
mental design is shown in Figure S1B. The successful transduc-
tion of EGFP (Figure 1H) and GDNF (Figure 1I) into the NAc of
mice using this system was confirmed. We first assessed social
interaction time and sucrose preference for nonstressed B6mice
2 weeks after the injections of PEI/Gdnf or PEI/Egfp complexes.
We found that GDNF overexpression increased the social
interaction time (Figure 1J), but not the sucrose preference
(Figure 1K).We next investigated the effect of GDNF overexpres-
sion in stressful conditions. BALB mice were subjected to
4 weeks of CUMS and injected bilaterally into the NAc with either
PEI/Gdnf or PEI/Egfp complexes on day 14 of the CUMS
session. After the CUMS session, we performed behavioral
assays. We found that the social interaction time (Figure 1J)
and sucrose preference (Figure 1K) of the stressed BALB mice
that received PEI/Gdnf complexes were significantly greater
than those of the mice receiving PEI/Egfp complexes. These
results suggest a crucial role for GDNF in social interactions
and sucrose preference. The transcriptional regulation of Gdnf
in the NAc may also be involved in the development of suscep-
tibility and adaptation to CUMS.
Regulation of Histone Modifications by CUMS
and Continuous IMI Treatment
To explore the molecular mechanisms by which CUMS alters
Gdnf mRNA levels, resequence analysis of the Gdnf promoter
(4000 base pairs) was performed on BALB and B6 mice. No
differences were observed between the two mice strains
(data not shown), suggesting that epigenetic regulations may
account for altered Gdnf expression in stressed mice. Next,
we measured the levels of several posttranslational histone
modifications to the Gdnf promoter in vSTR tissues using
a ChIP assay. We found several differences in the histone
modifications of both BALB and B6 mice after CUMS and/or
continuous IMI treatment. Q-PCR measurements indicated
that Gdnf promoter-containing DNA fragments were signifi-
cantly less common in the acetylated histone 3 (H3ac) immuno-
precipitates prepared from stressed BALB mice. This effect
was reversed by continuous IMI treatment (Figure 2A).
Acetylated histone 4 (H4ac) levels at the Gdnf promoter
were not affected by either CUMS or continuous IMI treat-
ment (Figure 2B). In stressed B6 mice, H3ac levels at
the Gdnf promoter, but not H4ac levels, were significantly
increased by CUMS (Figures 2A and 2B). We also examined
the effects of CUMS on the level of trimethylated histone 3 at
lysine 27 (H3K27me3) and trimethylated histone 3 at lysine362 Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc.4 (H3K4me3), which are the respective repressive and acti-
vating markers of transcription, at the Gdnf promoter. The
levels of H3K27me3 were not affected by CUMS and IMI in
BALB mice, but they were significantly reduced in B6 mice
by CUMS (Figure 2C). The levels of H3K4me3 were significantly
reduced by CUMS in both strains, and this reduction was
reversed by IMI in stressed BALB mice (Figure 2D). These
data suggest that histone modifications to the Gdnf promoter
in response to CUMS are differentially regulated in each mouse
strain.
Next, we investigated the mechanisms underlying the
changes in the histone acetylation of the Gdnf promoter. We
hypothesized that the altered expression of histone deacety-
lases (HDACs) could account for the altered level of histone
acetylation. The levels of mRNA for HDACs (HDAC 1–11)
were measured in the vSTR of BALB mice using Q-PCR. Several
significant changes in Hdacs expression were observed
following CUMS and/or continuous IMI treatment (Figure 2E).
Of particular note, the mRNA level of Hdac2 in stressed
mice increased approximately two-fold compared with that of
nonstressed controls. This enhancement was reversed by
continuous IMI treatment. Changes at the protein level were
also determined using Western blot analysis (Figure 2F).
However, in the HP of BALB mice (Figure 2G) and the vSTR of
B6 mice (Figure 2H), there were no significant effects of CUMS
or IMI treatment on HDAC2 expression. Thus, these results
suggest that HDAC2 may be an important regulator of the
epigenetic repression ofGdnf expression in the vSTR of stressed
BALB mice.
To determine whether CUMS influences the binding of
HDAC2 to the Gdnf promoter, we performed a ChIP assay with
vSTR DNA. Q-PCR measurements indicated that Gdnf
promoter-containing DNA fragments are enriched in HDAC2
immunoprecipitates prepared from stressed BALB mice, and
this effect was reversed by continuous IMI treatment (Figure 2I).
No changes were observed at the Bdnf promoter II region (Fig-
ure S6A), whose transcript (Bdnf exon II) was not altered by
either CUMS or IMI treatment (Figure S6B). This finding validates
the specificity of the ChIP assay used in this study. In contrast to
BALB mice, there was no significant effect of CUMS on HDAC2
binding to the Gdnf promoter in B6 mice (Figure 2J).
Rapid Antidepressant Effects of SAHA
on CUMS-Induced Behavioral Deficits
Our data indicate that CUMS increases HDAC2 expression in the
vSTR of BALB mice but not in B6 mice. This observation led to
the hypothesis that this effect may be important for the transcrip-
tional repression of Gdnf and the behavioral susceptibility to
CUMS. To test the functional role of altered H3ac levels at the
Gdnf promoter and HDAC2 expression in stressed BALB mice,
suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor,
was systemically administered (25 mg/kg/day) for the last
5 days of each 6-week CUMS sessions and during behavioral
testing. In addition, to evaluate the possible antidepressant
effects of SAHA, either IMI or fluoxetine (FLX), a selective
serotonin reuptake inhibitor, was administered (25 mg/kg/day).
The experimental design is shown in Figure S1C. The mice that
received subchronic SAHA but not subchronic IMI or FLX
Figure 2. Differential Regulations of Histone Modifications in Stress-Susceptible and Stress-Adaptive Mice Strains
(A–D) Levels of posttranslational histonemodifications in theGdnf promoter of the vSTR of BALB and B6mice subjected to CUMSor nonstressed (NS) conditions
with or without IMI treatment were measured using ChIP assays with antibodies for acetylated histone 3 (A), acetylated histone 4 (B), and histone 3 trimethylated
on lysine 27 (H3-K27 trimethylation) (C) or lysine 4 (H3-K4 trimethylation) (D) (n = 6 per group; *p < 0.05 versus NS mice receiving vehicle (normal water) in cor-
responding strains).
(E) mRNA levels ofHdacs in the vSTR of BALBmice subjected to CUMS or NS conditions with or without IMI treatment (n = 6 per group; *p < 0.05 versus NSmice
receiving water).
(F and G) Western blot analysis of HDAC2 protein levels in the vSTR (F) and HP (G) of BALB mice subjected to CUMS or NS conditions with or without IMI treat-
ment (n = 7–8 per group; *p < 0.05 versus NS mice receiving water).
(H) mRNA and protein levels of HDAC2 in the vSTR of stressed B6 mice (n = 6 per group).
(I and J) HDAC2 levels at theGdnf promoter in the vSTR of BALB (I) and B6 (J) mice weremeasured using ChIP assays with a specific antibody for HDAC2 (n = 7–8
per group; *p < 0.05 versus NS mice receiving water). Data are presented as mean ± SEM.
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vehicle-treatedmice in stressed conditions (Figure 3A). Similarly,
the sucrose preference of mice receiving SAHA, but not IMI or
FLX, was significantly increased compared to that of mice
receiving vehicle in stressed conditions (Figure 3B). In the
novelty-suppressed feeding test, SAHA reduced the latency to
feed in mice from both the nonstressed and the stressed condi-
tions, whereas subchronic IMI and FLX treatments did not affect
the latency to feed (Figure 3C). In addition, the immobility times
during the forced swim test were significantly decreased for
mice receiving SAHA, but not IMI or FLX, compared to vehicle-
treated mice from both the nonstressed and the stressed condi-
tions (Figure 3D). Furthermore, subchronic SAHA treatment, but
not IMI or FLX treatments, increased the mRNA levels of Gdnf in
the vSTR of stressed mice (Figure 3E). These data suggest that
HDAC inhibition can reverse both the increased depression-
like behaviors and the reduction of Gdnf expression by CUMS.
Our results also imply that SAHA has a more rapid antidepres-
sant effect than IMI and FLX.Role of HDAC2 in Behavioral Responses to CUMS
To test the direct contribution of HDAC2 in the NAc to CUMS-
induced depression-like behaviors, dominant-negative HDAC2
(dnHDAC2; HDAC2 H141A) was overexpressed in the NAc of
BALB mice using adeno-associated virus (AAV)-mediated gene
transfer. Replacing His141 with Ala in the catalytic domain of
HDAC2 reduces deacetylase activity by 75% (Humphrey et al.,
2008). The experimental design is shown in Figure S1D. The
successful transduction of AAV-mediated dnHDAC2 and control
EGFP was first confirmed: EGFP fluorescence was observed in
the NAc (Figure 3F), and Western blot analysis showed that
dnHDAC2 was overexpressed in the vSTR region (Figure 3G).
The NAc was then bilaterally infected with AAV-dnHDAC2 or
AAV-EGFP. Seven days after the injection of AAV, mice
were subjected to CUMS for 4 weeks, followed by the social
interaction and sucrose preference tests. Mice that received
AAV-dnHDAC2 exhibited increased social interaction times (Fig-
ure 3H) and sucrose preferences (Figure 3I) compared with the
mice that received AAV-EGFP. Furthermore, the mRNA levelsNeuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc. 363
Figure 3. Inhibition of HDAC2 Function Leads to a Stress-Resilient Phenotype
(A–E) Either SAHA, IMI, FLX, or saline were intraperitoneally administered (25 mg/kg of body weight for all drugs) on the last 5 days of each 6-week period of
CUMS or nonstressed (NS) conditions and during behavioral testing. The social interaction times (n = 15–19 per group), (B) sucrose preferences (n = 18-20
per group), (C) latencies to feed (n = 18–20 per group), (D) immobility times (n = 18–20 per group), and (E) mRNA expression levels of Gdnf in the vSTR (n = 8
per group) are shown (*p < 0.05).
(F and G) Successful transductions of EGFP (F) and dominant-negative HDAC2 (dnHDAC2; G) using AAV-mediated gene transfer are shown.
(H–J) Effects of dnHDAC2 overexpression induced by AAV-mediated gene transfer in the NAc of BALBmice subjected to CUMS on (H) the social interaction time
test (n = 14–15 per group), (I) the sucrose preference test (n = 17–19 per group), and (J) the Gdnf mRNA levels (n = 8 per group; *p < 0.05).
(K and L) Effects of the overexpression of wild-type HDAC2 (wtHDAC2) or the HDAC2C262/274Amutant induced by AAV-mediated gene transfer in the NAc of B6
mice on the (K) social interaction time (n = 14–15 per group) and (L) mRNA levels of Gdnf (n = 8 per group; *p < 0.05). Data are presented as mean ± SEM.
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dnHDAC2 were significantly increased compared to those of
stressed mice injected with AAV-EGFP (Figure 3J). These results
strongly suggest that the CUMS-induced activation of HDAC2
represses Gdnf transcription in the NAc, which results in aber-
rant behavioral responses in BALB mice.
To investigate the influence of HDAC2 on adaptive responses
to CUMS in B6 mice, we overexpressed wild-type HDAC2 in the
NAc of B6 mice and examined social interaction time and Gdnf
expression. Stressed mice injected with AAV-HDAC2 did not
show a reduction in social interaction time (Figure 3K) or Gdnf
expression (Figure 3L) when compared with stressed mice in-
jected with AAV-EGFP. A recent report showed that the nitrosy-
lation of HDAC2 induces its release from chromatin, which
promotes transcription. In the HDAC2 C262/274Amutant, which
lacks S-nitrosylation sites, HDAC2 strongly associates with
chromatin, thus repressing transcription (Nott et al., 2008). We
investigated the effects of HDAC2 C262/274A overexpression364 Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc.in the NAc of stressed B6 mice on social interaction and
Gdnf expression. We found that stressed mice injected with
AAV-HDAC2 C262/274A showed a reduction in social interac-
tion time (Figure 3K) and Gdnf expression (Figure 3L) compared
with stressed mice injected with AAV-EGFP. These results indi-
cate that the gain of function of HDAC2 in B6 mice leads to
a lack of active response to CUMS.
In contrast, the overexpression of the HDAC2 C262/274A
mutant in nonstressed B6 mice did not affect the social interac-
tion time or Gdnf expression (Figures 3K and 3L). Similar effects
were also observed in nonstressed BALBmice receiving bilateral
injections of either AAV-HDAC2 or AAV-HDAC2 C262/274A into
the NAc (Figure S7). These manipulations did not alter the social
interaction time (Figure S7B), sucrose preference (Figure S7C),
or Gdnf expression (Figure S7D). These data suggest that other
molecular mechanisms modulated by CUMS may also be
involved in the HDAC2-mediated Gdnf repression and subse-
quent behavioral alterations.
Figure 4. CUMS Induces Hypermethylation of the Gdnf Promoter and Increases MeCP2 Binding to Its Promoter in Both Mice Strains
(A) Position of the CpG sites within the mouse Gdnf promoter.
(B) Methylation of the Gdnf promoter showing the frequency of methylation observed at each CpG site for the HP and vSTR (n = 8 per group; *p < 0.05).
(C) Mean percentages of the methylated clones for the HP and vSTR. Themethylation percentage was calculated as the number of clones with at least one meth-
ylated CpG site divided by the total number of clones (n = 8 per group; *p < 0.05).
(D) mRNA levels of Gdnf in the HP, vSTR, dSTR, and prefrontal cortex (PFC) are shown (n = 6).
(E) CpGmethylation profiles in the vSTR of stressed (CUMS) BALBmice with or without continuous IMI treatment, and nonstressed (NS) mice (n = 7–8 per group;
*p < 0.05 versus NS mice receiving vehicle [normal water]).
(F) Samples of the sequence fluorograms obtained using bisulfite sequencing of DNA isolated from the vSTR of CUMS- and NS-BALB mice are shown. Arrows
indicate methylated and nonmethylated sequences of CpG site 2.
(G) Mean percent of the methylation of CpG site 2 at the Gdnf promoter in stressed B6 mice (n = 7–8 per group; *p < 0.05).
(H)MeCP2 occupancy at theGdnf promoter in theHP and vSTRweremeasured usingChIP analysiswith antibodies specific toMeCP2 (n = 6 per group; *p < 0.05).
(I) MeCP2 levels at the Gdnf promoter and Bdnf promoter II were measured by ChIP analysis of vSTR DNA from mice subjected to CUMS (n = 7–8 per group;
*p < 0.05 versus NS mice receiving water in the corresponding strain). Data are presented as mean ± SEM.
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Promoter in Both Strains
Previous reports have suggested that histone methylation can
affect DNA methylation at specific promoter regions (Lachner
and Jenuwein, 2002). To investigate whether CUMS and/or
IMI-induced alterations in the levels of H3K27me3 and
H3K4me3 at the Gdnf promoter (Figures 2C and 2D) correlate
with an increase in DNA methylation, DNA methylation assayswere performed. Cytosine methylation is a highly stable epige-
netic process that regulates gene expression through its effects
on transcription factor binding (Bird, 2001). Computational
analysis (Takai and Jones, 2003) predicted that the Gdnf
promoter has CpG islands adjacent to the transcription start
site (CG> 60%, observedCpG/expected CpG> 0.81, and length
> 300 bp; Figure 4A). Furthermore, these CpG islands are highly
conserved in mice, rats, and humans (data not shown). First, toNeuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc. 365
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methylated in vivo, the methylation levels of each CpG site
were measured within the Gdnf promoter and a portion of the
first exon. We used sodium bisulfite mapping to examine the
methylation status of individual CpG sites within Gdnf. This
method can detect both 5-methylcytosine and 5-hydroxy-meth-
ylcytosine. Sequence analysis of the bisulfite-converted DNA
isolated from the HP and vSTR of BALB mice revealed less
methylation at CpG sites 2 and 8–12 in the vSTR compared
with congruent CpG sites in the HP (Figure 4B). In addition,
sodium bisulfite mapping revealed a significantly lower
percentage of methylated clones in the vSTR compared with
the HP (Figure 4C). Concomitantly, the mRNA level of Gdnf in
the vSTR was approximately 13-fold higher than that of the HP
(Figure 4D), suggesting an association between the CpGmethyl-
ation level and Gdnf mRNA expression in vivo. Therefore, the
effects of 6 weeks of CUMS and continuous IMI treatment on
CpG methylation were analyzed with bisulfite-converted DNA
isolated from the vSTR of BALB mice. As indicated in Figures
4E and 4F, CUMS significantly increased methylation levels at
CpG sites 2 and 3, but these hypermethylations were reversed
by IMI treatment. Unexpectedly, the level of methylation at
CpG site 2, but not at site 3, was also increased by CUMS in
the vSTR of B6 mice (Figure 4G and data not shown).
CUMS Increases the Binding of MeCP2
at the Gdnf Promoter in Both Strains
The binding of methyl-CpG binding proteins (MBDs; MBD1,
MBD2, MBD3, MBD4, and MeCP2) to the target gene promoter
is a precise mechanism of gene transcription. Among MBDs,
MeCP2 is most abundantly expressed as a chromosomal protein
and requires a single methylated CpG site for preferential binding
toDNA (Nan et al., 1997; Jones et al., 1998). Therefore, the binding
of MeCP2 to the Gdnf promoter was directly assessed using the
ChIP assay. First, to determine whether there is a difference in
binding of MeCP2 to this promoter in the HP and vSTR of naive
adult BALB mice, Q-PCR analysis of recovered DNA was per-
formed using Gdnf promoter-specific primers. Gdnf promoter-
containing DNA fragments were significantly less common in
MeCP2 immunoprecipitates prepared from the vSTR compared
with those from the HP (Figure 4H). Q-PCR analysis of the same
immunoprecipitates was performed with a specific primer for
Gdnf exon 3, which has no CpG island, and the immunoprecipi-
tated DNA fragments were less common or undetectable (data
not shown), validating the specificity of the ChIP protocol used.
Next, the effect of 6weeks ofCUMSand continuous IMI treatment
on the binding ofMeCP2 to theGdnfpromoterwas analyzed in the
vSTR (Figure 4I). ChIP analysis revealed that CUMS significantly
increased MeCP2 binding to the Gdnf promoter in both BALB
and B6 mice, and continuous IMI treatment reversed this effect
in stressed BALB mice. There was no significant difference in
thebindingofMeCP2 to theBdnfpromoter II region,whichwasas-
sessed as a control. These results indicate that CUMS enhances
the binding ofMeCP2 to theGdnfpromoter in bothmouse strains.
We next investigated the functional role of methylated
CpG site 2 on Gdnf expression in Neuro2a cells. Treatment of
these cells with 5-aza-20-deoxycytidine, an inhibitor of DNA
methylation, reduced the methylation level at the Gdnf promoter366 Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc.(Figure S8A) and concomitantly increased Gdnf mRNA expres-
sion (Figure S8B). Next, the promoter activity of a CpG site
2-specific methylated Gdnf luciferase reporter gene was investi-
gated. We found that CpG site 2-specific methylation resulted in
an approximately 68% decrease in reporter activity when
MeCP2 and HDAC2 were cotransfected into Neuro2a cells (Fig-
ure S8C). Previous reports have indicated that the high-affinity
binding of MeCP2 to methylated DNA requires a run of four or
more A/T bases adjacent to the methylated CpG site (Klose
et al., 2005). We found two runs of A/T motifs located down-
stream of CpG site 2 (Figure S8D). To test the role of thesemotifs
on Gdnf promoter activity, wild-type and mutant reporters were
constructed for the A/T motifs in CpG site 2 (m1, m2, and m3;
Figure S8D). Then, the promoter activity of the CpG site
2-specific methylated and nonmethylated luciferase reporters
was measured using cotransfection experiments with MeCP2
and HDAC2 in Neuro2a cells (Figure S8E). We found that in
nonmethylated conditions, there was no mutation effect on
reporter activity by cotransfection with MeCP2 and HDAC2,
whereas in the specific methylation of CpG site 2, the reporter
activities of wild-type and m1 and m2 mutants, but not m3
mutant, were affected by HDAC2 and MeCP2 overexpresson.
These results suggest that the A/T motifs adjacent to CpG site
2 are critically involved in the MeCP2-HDAC2-mediated
silencing of Gdnf transcription. Furthermore, we found that
among the MBDs, MeCP2 was the most potent repressor of
the CpG site 2-specific methylated reporter vector (Figure S8F).
Together with the results observed in vivo, these findings
suggest that the methylation of CpG site 2 is important for the
epigenetic repression of Gdnf expression.
CUMS Increases the Binding of MeCP2-HDAC2
to the Gdnf Promoter in BALB Mice
The decreased expression level of Gdnf after CUMS in BALB
micewas investigated to determine if it is triggered by the binding
of MeCP2-HDAC2 complexes to the methylated CpG site of the
Gdnf promoter. This hypothesis was supported, in part, by the
finding that MeCP2 and HDAC2 are colocalized in the NAc (Fig-
ure 5A). The interactions of MeCP2 and HDAC2 were assessed
using IP-Western blot analysis of vSTR proteins. We found that
CUMS increased the formation of MeCP2-HDAC2 complexes
in stressed BALB mice. This effect was reversed by continuous
IMI treatment (Figure 5B). Next, to investigate the effect of
CUMS on the binding of MeCP2-HDAC2 complexes at the
Gdnf promoter, we performed re-ChIP assays using an antibody
for HDAC2 on the vSTR samples that were initially immunopre-
cipitated with an antibody for MeCP2. The re-ChIP assays indi-
cated that the Gdnf promoter-containing DNA fragments of
stressedBALBmice, but not B6mice,were significantly enriched
compared with those of nonstressed mice, and this effect was
reversed by continuous IMI treatment (Figure 5C). These results
suggest that the CUMS-induced binding of MeCP2-HDAC2
complexes to the Gdnf promoter silences its transcription.
To investigate the role of DNA methylation in the CUMS-
induced suppression of Gdnf expression and on depression-
like behaviors, zebularine (ZEB), a DNA methyltransferase
inhibitor, was continuously delivered into the NAc of BALB mice
by an osmotic pump. The experimental design is shown in
Figure 5. Increased MeCP2-HDAC2 Occupancy at
the Gdnf Promoter in Stressed BALB Mice
(A) Immunohistochemistry for HDAC2 andMeCP2 demon-
strated strong nuclear staining in the NAc. Scale bar,
100 mm.
(B) Nuclear extracts prepared from the vSTR of stressed
(CUMS) or nonstressed (NS) BALB mice with or without
IMI treatment were immunoprecipitated to evaluate the
association of HDAC2 with MeCP2.
(C) Q-PCR assays of the reimmunoprecipitates of HDAC2
antibodies of ChIP samples treated with MeCP2 anti-
bodies (re-ChIP assay) showed that Gdnf promoter-con-
taining DNA fragments were enriched in stressed BALB
mice (n = 6–8 per group; *p < 0.05 versus NS mice
receiving vehicle). Data are presented as mean ± SEM.
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4 weeks of CUMS, followed by behavioral and expression
analyses. We found that the social interaction times and sucrose
preferences of stressedmice receiving ZEB (100 mM)were signif-
icantly higher compared with those times and preferences of
vehicle-treated mice (Figures 6A and B). In the novelty-sup-
pressed feeding test, the latency to feed was significantly
decreased in stressed mice receiving ZEB compared with
vehicle-treated controls (Figure 6C). In the forced swim test, the
immobility times were significantly shorter in stressed and non-
stressed mice receiving ZEB compared with the times of
vehicle-treated mice (Figure 6D). Furthermore, the mRNA levels
of Gdnf in ZEB-treated mice were greater than the levels in
vehicle-treated mice (Figure 6E) in stressed conditions. These
findings confirm that there is less DNA methylation of CpG site
2 at the Gdnf promoter in stressed mice treated with ZEB
compared with vehicle-treated mice (Figure 6F). We also tested
whether intra-NAc delivery of RG108, a potent, nonnucleoside
inhibitor of DNAmethylation, could reverse the increaseddepres-
sion-like behaviors in BALB mice. Similar to the effects of ZEB,
continuous delivery of RG108 (100 mM) directly into the NAc
increased thesocial interaction time (Figure 6G) andsucrosepref-
erence (Figure 6H) ofmice in the stressedcondition. Furthermore,
we found that CUMS increased the mRNA expressions for DNA
methyltransferase 1 (DNMT1) and DNMT3a, but not DNMT3b,
in the vSTR of stressed mice. This effect was reversed by contin-
uous intra-NAc delivery of ZEB and RG108 (Figure 6I). These
results suggest that DNA methylation is critical for the CUMS-
inducedGdnf repression and subsequent depression-like behav-
iors in BALB mice. Our data also suggest that the continuous
intra-NAc delivery of DNMT inhibitors represses the expression
of Dnmts at the transcription level in postmitotic neurons.
CUMS Increases Binding of MeCP2-CREB
to the Gdnf Promoter in B6 Mice
Although DNA methylation is generally thought to be associated






lsuggested that the binding of a complex of
MeCP2 and cyclic AMP response element
(CRE)-binding protein (CREB) to the methylated
CpG site can activate transcription (Chahrour
et al., 2008). Interestingly, the putative CREsite is adjacent to CpG site 2 of the Gdnf gene (Figure 7A). In
addition, we found that MeCP2 and CREB are colocalized in
the NAc (Figure 7B). These facts led us to speculate that the
binding of the MeCP2-CREB complex to the Gdnf promote
may be a causal mechanism of the increased Gdnf expression
in stressed B6 mice. To test this possibility, we assessed the
interactions of MeCP2 and CREB in vSTR proteins of B6 and
BALB mice. IP-Western blot analysis showed that there is no
apparent difference in the formation of MeCP2-CREB
complexes between stressed and nonstressed mice in both
strains (Figure 7C). Next, to investigate the binding of MeCP2-
CREB complexes at the Gdnf promoter, we performed re-ChIP
assays using an antibody for CREB on vSTR samples that had
been initially immunoprecipitated with an antibody for MeCP2
Consistent with a previous report (Chahrour et al., 2008)
CREB-MeCP2 complexes on the somatostatin promoter were
enriched, whereas they were reduced on the myocyte enhance
factor 2c promoter (data not shown), validating the specificity o
the re-ChIP used. We found that the Gdnf promoter-containing
DNA fragments of stressed B6 mice were significantly enriched
in the reimmunoprecipitates of samples treated with CREB anti-
bodies compared with those of nonstressed mice. This effec
was not seen in stressed BALB mice (Figure 7D). These results
suggest that the CUMS-induced binding of MeCP2-CREB
complexes to the Gdnf promoter leads to the activation of its
transcription.
DISCUSSION
This study used genetically distinct inbred mouse strains to
describe one of the molecular mechanisms underlying suscepti-
bility and adaptation responses to chronic stress. The proposed
mechanisms underlying stress susceptibility and adaptation
are described in Figure 7E. Our results suggest that CUMS
increases DNA methylation at CpG site 2, and this is associated
with increased MeCP2 binding. MeCP2 associated with CpG
site 2 interacts with HDAC2, which in turn decreases the leve
Figure 6. Effects of a DNA Methyltransferase Inhibitor on CUMS-Induced Depression-Like Behaviors and Gdnf mRNA Expression
Either ZEB (10 mM or 100 mM) or a vehicle control was continuously and bilaterally delivered into the NAc of BALB mice. After each 4-week CUMS session, the
depression-like behaviors of mice were analyzed.
(A–D) Social interaction times (n = 9–12 per group), (B) sucrose preferences (n = 10–12 per group), (C) latencies to feed (n = 10–12 per group), and (D) immobility
times (n = 10–12 per group) are shown (*p < 0.05).
(E) The mRNA levels of Gdnf in the vSTR were measured by Q-PCR (n = 6–8 per group; *p < 0.05).
(F) Mean percent methylation of CpG site 2 at the Gdnf promoter in stressed BALB mice receiving ZEB (100 mM) or vehicle (n = 6 per group; *p < 0.05).
(G and H) RG108 (10 mM or 100 mM) or vehicle was continuously and bilaterally delivered into the NAc of stressed BALB mice. After each 4-week CUMS session,
the (G) social interaction time (n = 9–12 per group) and (H) sucrose preference (n = 11–15 per group) of the subjects were analyzed (*p < 0.05).
(I) ThemRNA levels ofDnmt1,Dnmt3a, andDnmt3b in the vSTR of mice receiving ZEB or RG108 (100 mM) were measured by Q-PCR (n = 6–8 per group; *p < 0.05
versus NS mice receiving vehicle). Data are presented as mean ± SEM.
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tion, leading to the formation of a more depression-susceptible
phenotype in BALB mice. Continuous IMI treatment relieves
MeCP2 occupancy and reverses HDAC2 levels, which leads to
normal levels of H3 acetylation and subsequent Gdnf transcrip-
tion, resulting in normal emotional behaviors. Although increased
DNA methylation at CpG site 2 and increased MeCP2 occu-
pancy were also observed after CUMS exposure in B6 mice,
the acetylation levels of H3 and Gdnf expression were greater.
Importantly, we found evidence for the binding of the MeCP2-
CREB complex to themethylated CpG site on theGdnf promoter
in stressed B6 mice. This may be a causal mechanism for the
induction of Gdnf expression in stressed B6 mice. Thus, our
data provide evidence that differential epigenetic marks in the368 Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc.NAc, along with environmental and genetic factors, may influ-
ence either the susceptibility or adaptation responses of an
organism to chronic daily stressful events.
Role of GDNF in Stress Responses
NAc has been implicated in the development of depression-like
behaviors and has an influence on the action of antidepressants
(Charney and Manji, 2004; Krishnan and Nestler, 2008; Feder
et al., 2009). The data presented here indicate that differential
histone modifications at the Gdnf promoter between stressed
BALB and B6mice result in differential levels ofGdnf expression.
Overexpression of GDNF in the NAc increased social interaction
times and sucrose preference in the stressed and/or the non-
stressed conditions. Conditional GDNF knockout mice showed
Figure 7. Increased MeCP2-CREBOccupancy at theGdnf Promoter
in Stressed B6 Mice
(A) Positions of the CpG site 2 and putative CREB-binding site within the Gdnf
promoter.
(B) Immunohistochemistry for MeCP2 and CREB demonstrated strong nuclear
staining in the NAc. Scale bar, 100 mm.
(C) Nuclear extracts prepared from the vSTR of stressed (CUMS) or non-
stressed (NS) B6 mice were immunoprecipitated to evaluate the association
of MeCP2 with CREB.
(D) Q-PCR analyses of reimmunoprecipitates for CREB antibodies of ChIP
samples treated with MeCP2 antibodies (re-ChIP assay) showed that Gdnf
promoter-containing DNA fragments were enriched in stressed B6 mice (n =
4–5 per group; *p < 0.05 versus NSmice). Data are presented as mean ± SEM.
(E) Proposed mechanisms detailing how the chromatin microenvironment at
the Gdnf promoter regulates its expression after CUMS exposure with or
without IMI treatment in BALB and B6mice. This study proposes that dynamic
epigenetic changes in the Gdnf promoter may serve either as a repressive or
activating marker of transcription in the NAc, and these changes may serve
as causal mechanisms of the different behavioral responses to stress in
BALB and B6 mice (refer to the Discussion for more details).
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et al., 2008). In addition, mice that are not susceptible to social
defeat stress show increased Gdnf expression in the ventral
tegmental area (VTA) (Krishnan et al., 2007). The VTA-NAc
network of the mesolimbic dopamine system may be involved
in susceptibility and resistance responses to chronic stress
(Nestler and Carlezon, 2006; Krishnan et al., 2007). GDNF
promotes the survival and maintenance of midbrain dopamine-
containing neurons, and GDNF protects neurons in the dopa-
mine system from various toxic stimuli (Lin et al., 1993; Bespalov
and Saarma, 2007; Pascual et al., 2008). Thus, the data
presented here support the hypothesis that the mesolimbic
dopamine system is involved in the formation of susceptibility
and resistance responses to chronic stress.
In our experiments, continuous IMI treatment rescued the
reduced GDNF expression in the vSTR of stressed BALB mice,
suggesting that GDNF is also involved in the behavioral
responses to antidepressants. The rescue of GDNF expression
in stressed BALB mice returned behavioral performances back
to control levels. However, it is still unclear whether the IMI-medi-
ated upregulation of GDNF expression is critically involved in the
antidepressant responses. IMI treatment also enhanced the
mRNA expressions for other neurotrophic factors, including
BDNF and VEGF, in multiple brain regions of BALB mice, and
thesemolecules are thought to be associatedwith the behavioral
responses to antidepressants (Warner-Schmidt and Duman,
2007; Krishnan and Nestler, 2008). Thus, we cannot exclude
the possibility that molecules other than GDNF are important
for the behavioral effects of antidepressant in the animal models
used this study. Further experiments are needed to clarify the
role of GDNF in the behavioral responses to antidepressants.
CUMS and Antidepressants Affect Histone
Modifications in the Gdnf Promoter
Persistent depressive symptoms suggest the involvement of
stable changes in gene expression in brain, which may reflect
a degree of chromatin remodeling, such as histone acetylation
(Krishnan and Nestler, 2008; Tsankova et al., 2007). Recent
reports have suggested that modulations of histone acetylation
by HDAC2 and HDAC5 are also involved in the actions of antide-
pressants (Tsankova et al., 2006; Covington et al., 2009). In addi-
tion, subchronic administration of SAHA directly into the NAc of
mice reverses the reduced social interaction time caused by
social defeat stress (Covington et al., 2009). Similarly, this study
demonstrated that the increased depression-like behaviors
caused by CUMS were reversed by the subchronic administra-
tion of SAHA and the overexpression of dnHDAC2. However,
nonstressed mice that received subchronic SAHA treatment
did not exhibit any observable effects in their social interaction
times, sucrose preferences, or expression levels of Gdnf
mRNA. Taken together, these findings suggest that the hyperac-
tive HDACs are involved in the reduction ofGdnf expression and
subsequent depression-like behaviors induced by CUMS. In
addition, we found that the overexpression of the HDAC2
C262/274A mutant, but not wild-type HDAC2, in the NAc
of stressed B6 mice decreased social interaction time and
Gdnf expression, suggesting a possible contribution of the
S-nitrosylation of HDAC2 to the stress responses. We also foundNeuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc. 369
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in both BALB and B6 mice, whereas the levels of H3K27me3 at
its promoter were decreased only in B6 mice. These findings
seem to be inconsistent with regard to the levels ofGdnf expres-
sion. The reduced H3K4me3 level at the Gdnf promoter in the
NAc may be a common mechanism for responses to CUMS,
and the reduced H3K27me3 level may be one of the important
mechanisms modulating the chromatin microenvironment that
primes adaptation responses to CUMS.
DNAMethylation at theGdnfGene Promoter Is Required
for Both Susceptible and Adaptive Responses to CUMS
In addition to histone acetylation, the data presented here
suggest an important role for DNA methylation in Gdnf expres-
sion and the subsequent behavioral responses to chronic stress.
The epigenetic molecular mechanisms of DNA methylation in
the brain may play important roles in the regulation of synaptic
plasticity, memory formation, and stress responses (Weaver
et al., 2004; Levenson and Sweatt, 2005; Krishnan and Nestler,
2008; Feder et al., 2009). Our data indicate that CUMS enhances
DNA methylation at particular CpG sites on the Gdnf promoter
in BALB mice. Importantly, our work indicates that the
CUMS-induced depression-like behaviors and reduced Gdnf
expression were reversed by the intra-NAc delivery of DNA
methyltransferase inhibitors, a result that has been replicated
in a recent report (LaPlant et al., 2010). Unexpectedly, the
increased DNA methylation and MeCP2 binding also occurred
in stress-resilient B6 mice. In general, DNA methylation is
primarily associated with the repression of gene transcription.
However, a recent study indicated that MeCP2-CREB
complexes have assumed the role of inducing target gene
expression (Chahrour et al., 2008). In addition, Gdnf expression
may be regulated by CREB (Cen et al., 2006). Together with
these findings, this study suggests that the binding of different
MeCP2 complexes (i.e., MeCP2-CREB and MeCP2-HDAC2) to
the methylated CpG site on the Gdnf promoter may be a causal
mechanism for the induction and repression of Gdnf expression
in the NAc of B6 and BALB mice.
Conclusion
This study provides insights into the role that genetic factors, in
combination with environmental factors, may play in the epige-
netic regulation of Gdnf. Dynamic epigenetic regulations of the
Gdnf promoter in the NAc play important roles in determining
both the susceptibility and the adaptation responses to chronic
stressful events. Elucidation of the mechanisms underlying the
modulations of HDAC2 expression, histone modifications, and
DNA methylation influenced by CUMS could lead to novel
approaches for the treatment of depression.
EXPERIMENTAL PROCEDURES
Details can be found in the Supplemental Experimental Procedures.
Animals
Adult male C57BL/6J and BALB/cmice (Charles River Japan) weremaintained
on a 12 hr/12 hr light/dark cycle with mouse chow and water ad libitum. Four
mice were housed in each cage. Eight- or nine-week-old mice were used at
the start of experiments (i.e., CUMS, stereotaxic surgery). All experimental370 Neuron 69, 359–372, January 27, 2011 ª2011 Elsevier Inc.procedures were performed according to the Guidelines for Animal Care
and Use at Yamaguchi University Graduate School of Medicine.CUMS Procedure
The CUMSprocedure has been previously described in detail (Lanfumey et al.,
1999; Rangon et al., 2007) and was conducted here with minor modifications.
This procedure was based solely on environmental and social stressors, which
did not include food/water deprivation. A total of three stressors were used in
this study. For the first stressor, two of the following five ultra-mild diurnal
stressors were delivered randomly over a period of 1–2 hr with a 2 hr stress-
free time period between the two stressors: a period of cage tilt (30), confine-
ment to a small cage (113 83 8 cm), paired housing, soiled cage (50 ml water
per 1 l of sawdust bedding), and odor (10% acetic acid), The second stressor
consisted of four ultra-mild nocturnal stressors, including one overnight period
with difficult access to food, one overnight period with permanent light, one
overnight period with a 30 cage tilt, and one overnight period in a soiled
cage. For the third stressor, a reversed light/dark cycle was used from Friday
evening to Monday morning. This procedure was scheduled over a 1-week
period and repeated four or six times, but the reversed light/dark cycle was
omitted during the weekend of the last week (either the fourth or sixth week)
of the session. Nonstressed mice were handled everyday for weighing
purposes.Behavioral Procedures
Behavioral tests were performed during the light phase (9 a.m. to 2 p.m.) with
minor modifications, as reported previously (Uchida et al., 2008; 2010). All
behavioral tests were conducted by experimenters who were blind to the
treatment condition of the animal. Details can be found in the Supplemental
Experimental Procedures.Drugs
IMI, FLX, and 5-aza-20-deoxycytidine were purchased from Sigma. ZEB and
RG108 were purchased from Calbiochem. SAHA was synthesized as
described previously (Suzuki et al., 2009). Details can be found in the Supple-
mental Experimental Procedures.PEI-Mediated Gene Delivery
PEI-mediated gene delivery was performed as previously reported (Uchida
et al., 2010). Plasmid DNA/PEI complexes were prepared according to the
manufacturer’s instructions (in vivo-jet PEI; PolyPlus Transfection). Seven
days after bilateral canulae implantation into the NAc (+ 1.5 mm AP,
± 1.0 mmML,4.0 mmDV), mice were subjected to a 4-week CUMS session.
PEI/plasmid complexes (0.5 ml/hemisphere) were injected on day 14 of the
CUMS session. Details can be found in the Supplemental Experimental
Procedures.AAV-Mediated Gene Transfer
AAV-mediated gene transfer was performed as previously reported (Uchida
et al., 2010). The genomic titer of each virus was determined using Q-PCR.
The titers of AAV-EGFP, AAV-HA-HDAC2, AAV-HA-dnHDAC2, and AAV-
HA-HDAC2 C262/274A were measured as 5.6 3 1012 viral genomes (vg)/ml,
3.1 3 1012 vg/ml, 3.5 3 1012 vg/ml, and 2.1 3 1012 vg/ml, respectively. For
virus injections, the AAV vector (0.5 ml) was injected bilaterally into the NAc
(+ 1.5 mm AP, ± 1.0 mm ML, 4.5 mm DV) at a rate of 0.l ml/min. Mice were
allowed to recover for 1 week after surgery. Details can be found in the Supple-
mental Experimental Procedures.Statistical Analysis
Analyses of the datawere performed using an appropriate analysis of variance.
Significant effects were followed up with Bonferroni’s post hoc tests. Unpaired
t tests were used for two-group comparisons. Pearson correlations were
calculated to assess correlations between data. In all cases, p values were
two-tailed, and the comparisons were considered statistically significant
when p < 0.05. Data are presented as the mean ± SEM.
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